Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m14
10
infinite
0
TRANSPATH | MO000000058 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
RIP2
--
MO000017949
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2684
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000017949 |
--
Nod1
--
MO000020434
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4923
10
infinite
0
InterPro | IPR007091 |
TRANSPATH | MO000020434 |
--
Nod2
--
MO000020461
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m4947
10
infinite
0
TRANSPATH | MO000020461 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
Nod1 oligomer:PGN:RIP2
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m10
0
infinite
0
--
hPepT1
--
e11
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m11
0
infinite
0
--
NF-kappaB{active}
--
e14
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m15
10
infinite
0
TRANSPATH | MO000000058 |
--
Nod1 oligomer:PGN
--
e15
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m16
0
infinite
0
--
Nod1 oligomer:PGN:RIP2:IKK
--
e16
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m17
0
infinite
0
--
RIP2:CARD6
--
e17
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m18
0
infinite
0
--
Nod2 oligomer:PGN
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
Nod2 oligomer:PGN:RIP2
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
Nod2 oligomer:PGN:RIP2:IKK
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
TAK1:Nod2
--
e21
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m22
0
infinite
0
--
SGT1
--
e22
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m23
0
infinite
0
--
Nod1:SGT1
--
e23
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m24
0
infinite
0
--
Nod2:SGT1
--
e24
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m25
0
infinite
0
--
Nod2:Erbin
--
e25
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m26
0
infinite
0
--
GRIM-19
--
e26
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m27
0
infinite
0
--
Nod2:GRIM-19
--
e27
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m28
0
infinite
0
--
TNF-alphaR
--
e28
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m29
0
infinite
0
--
TNF-alpha:TNF-alphaR
--
e29
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IFNgammaR
--
e30
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m31
0
infinite
0
--
IFNgamma:IFNgammaR
--
e31
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m32
0
infinite
0
--
hBD-2
--
e32
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m33
0
infinite
0
--
hBD-2
--
e33
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m34
0
infinite
0
--
NO
--
e34
cso30:c:SmallMolecule
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m35
0
infinite
0
--
Ligand
--
e35
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m36
0
infinite
0
--
TLR:Ligand
--
e36
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m37
0
infinite
0
--
TLR
--
e37
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m38
0
infinite
0
--
Il-12
--
e38
cso30:c:mRNA
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m39
0
infinite
0
--
H pylori
--
e39
cso30:c:Cell
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
C. jejuni
--
e40
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m41
0
infinite
0
--
Nod2:PGN:NIK
--
e43
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m46
0
infinite
0
--
Nod1:PGN
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Nod2:PGN
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c5 : 1
m4923*m155701*0.1
nodelay
--
0
PMID: 18031249,12527755,12871942,12514169,12796777,12791997 Nod1 and Nod2 detect distinct sub-structures from bacterial peptidoglycan. Whereas Nod2 detects MDP (muramyl dipeptide; MurNAc-L-Ala-D-isoGln), the largest peptidoglycan motif common to Gram-negative and Gram-positive bacteria , Nod1 senses meso-DAP (meso-diaminopimelic acid)-containing peptidoglycan , which is more commonly found in Gram-negative bacteria.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m2684*m38143*0.1
nodelay
--
0
PMID: 18031249,16418290 In overexpression studies, CARD6 has been shown to bind RIP2, but affected Nod-dependent NF-kB activation only modestly
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m6*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m19*m2684*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m20*m207*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
p9
p14
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m21*m14*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m4947*m1573*0.1
nodelay
--
0
PMID: 18031249,15075345 Similarly, overexpressed TAK1 [TGF (transforming growth factor)-b-activated kinase 1] and Nod2 have been shown to interact
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m4923*m23*0.1
nodelay
--
0
PMID: 18031249,17420470,17435760 Two studies have found, using unbiased screens for identifying new Nod partners, that overexpressed Nod1 and Nod2 interact with SGT1 (suppressor of G2 allele of Skp1), a co-chaperone of HSP90 (heat-shock protein 90)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m4947*m23*0.1
nodelay
--
0
PMID: 18031249,17420470,17435760 Two studies have found, using unbiased screens for identifying new Nod partners, that overexpressed Nod1 and Nod2 interact with SGT1 (suppressor of G2 allele of Skp1), a co-chaperone of HSP90 (heat-shock protein 90)
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m4947*m12851*0.1
nodelay
--
0
PMID: 18031249,16203728,16714539 Two other studies have reported the interaction between Nod2 and Erbin, again relying on unbiased screens
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m4947*m27*0.1
nodelay
--
0
PMID: 18031249,15753091 Finally, using a yeast two-hybrid screen, Barnich et al.identified GRIM-19 (gene associated with retinoid-interferon-induced mortality 19) as a Nod2-interacting protein that is important for Nod2-mediated responses
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c4 : 1
stoichiometry:c6 : 1
m4947*m155701*0.1
nodelay
--
0
PMID: 18031249,12527755,12871942,12514169,12796777,12791997 Nod1 and Nod2 detect distinct sub-structures from bacterial peptidoglycan. Whereas Nod2 detects MDP (muramyl dipeptide; MurNAc-L-Ala-D-isoGln), the largest peptidoglycan motif common to Gram-negative and Gram-positive bacteria , Nod1 senses meso-DAP (meso-diaminopimelic acid)-containing peptidoglycan , which is more commonly found in Gram-negative bacteria.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m230*m29*0.1
nodelay
--
0
PMID: 18031249,12813035,12671897 Nod1 seems to be more ubiquitously and constitutively expressed in this cell type than Nod2, even though several studies showed the up-regulation of Nod2 by TNFa and IFNg (interferon g) in epithelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m30*0.1
nodelay
--
0
PMID: 18031249,12813035,12671897 Nod1 seems to be more ubiquitously and constitutively expressed in this cell type than Nod2, even though several studies showed the up-regulation of Nod2 by TNFa and IFNg (interferon g) in epithelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m1639*m31*0.1
nodelay
--
0
PMID: 18031249,12813035,12671897 Nod1 seems to be more ubiquitously and constitutively expressed in this cell type than Nod2, even though several studies showed the up-regulation of Nod2 by TNFa and IFNg (interferon g) in epithelial cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m32*0.1
nodelay
--
0
PMID: 18031249,12813035,12671897 Nod1 seems to be more ubiquitously and constitutively expressed in this cell type than Nod2, even though several studies showed the up-regulation of Nod2 by TNFa and IFNg (interferon g) in epithelial cells
p24
p24
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c105 : 1
stoichiometry:c68 : 1
m4923*m40*0.1
nodelay
--
0
PMID: 18031249,16513653 A recent study has demonstrated that Nod1 plays a key role in the induction of hBD-2 following infection of gastric cells with H. pylori PMID: 18031249,17521327 Similarly, sensing of C. jejuni by Nod1 was shown to induce hBD2 production, resulting in lowered bacterial colonization
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c106 : 1
stoichiometry:c70 : 1
m33*m41*0.1
nodelay
--
0
PMID: 18031249,16513653 A recent study has demonstrated that Nod1 plays a key role in the induction of hBD-2 following infection of gastric cells with H. pylori PMID: 18031249,17521327 Similarly, sensing of C. jejuni by Nod1 was shown to induce hBD2 production, resulting in lowered bacterial colonization
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m32*m5*0.1
nodelay
--
0
PMID: 18031249,17579072 iNOS is induced after Nod1 stimulation in mesothelial cells in synergy with IFNg
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m17*0.1
nodelay
--
0
PMID: 18031249,16211083,16585574,17579072 n primary macrophages, Nod1 and Nod2 pathways have been shown to induce the formation of NO
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m21*0.1
nodelay
--
0
PMID: 18031249,16211083,16585574,17579072 In primary macrophages, Nod1 and Nod2 pathways have been shown to induce the formation of NO
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m36*m38*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m12*m11*0.1
nodelay
--
0
PMID: 18031249,15521010 hPepT1 (human peptide transporter 1), a transmembrane transporter of di- or tri-peptides, has been shown to internalize MDP
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m5*m37*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m6*m37*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c89 : 1
m6*m37*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c90 : 1
stoichiometry:c92 : 1
stoichiometry:c91 : 1
m5*m37*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m37*m5*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c96 : 1
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m37*m6*0.1
nodelay
--
0
PMID: 18031249,16021602 In human primary DCs, Nod ligands were shown to induce, in synergy with TLR ligands, increased expression of several co-stimulatory molecules, CD80, CD86 and CD40
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c101 : 1
stoichiometry:c100 : 1
m37*m5*0.1
nodelay
--
0
PMID:18031249,16299289 Similarly, Nod and TLR ligands co-operate on DCs to trigger IL-12, a crucial cytokine in Th1 immunity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c102 : 1
m37*m6*0.1
nodelay
--
0
PMID:18031249,16299289 Similarly, Nod and TLR ligands co-operate on DCs to trigger IL-12, a crucial cytokine in Th1 immunity
p38
p38
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m17*m42*0.1
nodelay
--
0
PMID: 18031249,16552041,11463746,17420470 Nod1- and Nod2- dependent pathways also stimulate JNK (c-Jun N-terminal kinase) and p38 MAPK
p38
p39
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m21*m42*0.1
nodelay
--
0
PMID: 18031249,16552041,11463746,17420470 Nod1- and Nod2- dependent pathways also stimulate JNK (c-Jun N-terminal kinase) and p38 MAPK
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c119 : 1
stoichiometry:c10 : 1
m174*m6*0.1
nodelay
--
0
PMID: 18031249,16552041 In addition, a direct interaction between Nod2 and NIK (NF-kB-inducing kinase) has been reported to trigger the p100/p52-dependent induction of the non-canonical NF-kB pathway in murine primary macrophages
p38
p40
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m21*m44*0.1
nodelay
--
0
PMID: 18031249,16552041,11463746,17420470 Nod1- and Nod2- dependent pathways also stimulate JNK (c-Jun N-terminal kinase) and p38 MAPK
p38
p41
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m17*m44*0.1
nodelay
--
0
PMID: 18031249,16552041,11463746,17420470 Nod1- and Nod2- dependent pathways also stimulate JNK (c-Jun N-terminal kinase) and p38 MAPK
p5
p5
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c16 : 1
stoichiometry:c120 : 1
stoichiometry:c15 : 1
m14*m173*m46*0.1
nodelay
--
0
PMID: 18031249,16552041 In addition, a direct interaction between Nod2 and NIK (NF-kB-inducing kinase) has been reported to trigger the p100/p52-dependent induction of the non-canonical NF-kB pathway in murine primary macrophages
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m5*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m16*m2684*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m10*m207*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
p9
p9
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m17*m14*0.1
nodelay
--
0
PMID: 18031249 The current model shows that the oligomerization of Nod proteins following peptidoglycan sensing results in the recruitment of RIP2 (receptor-interacting protein 2), also known as RICK [Rip-like interacting CLARP (caspase-like apoptosis-regulatory protein) kinase], which in turn interacts with the IKK [IkB (inhibitor of NF-kB) kinase] complex, the converging knot of common NF-kB-activating pathways, including TLR-, IL-1- and TNF (tumour necrosis factor)-mediated signalling cascades.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--